SynopsisEculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In peopl.....
SynopsisThe Ophthalmic Laser Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players.....
SynopsisCell lysis equipment is a device used by laboratories or biopharmaceutical companies to effectively rupture cells such as animals, plants, fungi, algae, and etc. The global Cell Lysis Equipment market was valued at US$ XX million in 2019 and is ex.....
SynopsisThere are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected.....
SynopsisThe global Bulk Drug Intermediates market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. This report focuses on Bulk Drug Intermediates volume and value at the global.....
SynopsisThe global Fingertip Pulse Oximetry market size is expected to reach US$ 1666.3 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Fingertip Pulse Oximetry in various end use industries......
Synopsis Global Sodium Valproate Preparation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russi.....
Synopsis The global Measles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2.....
SynopsisOral Semaglutide is the first oral glucagon-like peptide 1 receptor agonist product for the treatment of type 2 diabetes mellitus.As a class, GLP-1 receptor agonists are widely used and recommended for the treatment of type 2 diabetes mellitus. The globa.....
SynopsisThe global Medication for Facial Features market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Aging population: As the global population ages, the demand f.....
